-- Mary Elizabeth Dallas
THURSDAY, Feb. 14 (HealthDay News) -- Sixteen cases of serious
kidney damage caused by synthetic marijuana products were reported
in six states last year, according to a new U.S. government study
Although no one died, all 16 people had to be admitted to
hospitals and five required hemodialysis, the report from the U.S.
Centers for Disease Control and Prevention (CDC) said. In
hemodialysis -- a treatment commonly used to treat advanced kidney
failure -- a person's blood is filtered to remove waste and extra
fluids, and then the clean blood is returned to the body.
The patients described in the CDC report ranged in age from 15
to 33, all but one were male, and none of them had a history of
"Synthetic cannabinoids, which are sold in smoke shops and convenience stores under names like 'synthetic marijuana,' 'Spice,' 'K2,' or 'herbal incense,' are designer drugs dissolved in solvent, applied to plant material, and smoked," the researchers explained. The report is published in the Feb. 15 issue of the CDC's Morbidity and Mortality Weekly Report.
The government report followed on the heels on new research
released last week that found that synthetic marijuana has been
directly linked to serious kidney damage.
Those researchers, from the University of Alabama at Birmingham,
pointed out that synthetic marijuana has become increasingly
popular over the past few years because such man-made drugs are
relatively cheap and difficult to detect with drug screening
They also suggested that doctors should suspect the use of
synthetic marijuana when patients, particularly young adults, have
unexplained acute kidney damage.
"Cases of acute coronary syndrome associated with synthetic marijuana use have been reported, but our publication is the first to associate use with acute kidney injury," study co-author Dr. Gaurav Jain, an assistant professor in the nephrology division, said in a university news release. Abnormally rapid heart rate and seizures have also been reported with synthetic marijuana use, he noted.
Jain's team examined four cases of acute kidney damage that were
linked to the use of synthetic marijuana. In each case, an
otherwise healthy young man went to the emergency room with nausea,
vomiting and abdominal pain after using the drug. All of the men,
the researchers noted, lived in the same town in northeastern
Alabama, and all of the cases occurred within a nine-week
Three of the men had an acute kidney injury that caused their
volume of urine to be abnormally low. The fourth man had a drop in
effective blood flow to the kidney. Three of the men had a kidney
biopsy that showed the death of cells in the kidney that secrete,
reabsorb, collect and transport urine. Although this condition can
lead to kidney failure, in these cases the men regained their
kidney function and did not need dialysis, the study authors noted
in the news release.
Because all of the men had used synthetic marijuana, the doctors
suggested that how the drug is manufactured may have played a role
in its dangerous effects to the kidneys. They pointed out that
synthetic marijuana is made with certain additives, which may be
toxic to the kidneys.
However, the investigators could not confirm that the drug's
preparation causes kidney damage because they couldn't analyze
samples of the synthetic marijuana the men took or the men's blood
and urine samples, which were no longer available.
"There is very little information regarding the ingredients in synthetic cannabinoids that are sold on the streets, although it is known that additional compounds are added to the preparations," said Jain. He suggested that it is "very likely" that a substance that is toxic to the kidney was added to the drug used by the patients.
The doctors concluded that patients with acute kidney injury
should be asked about use of designer drugs, such as synthetic
marijuana. "If they don't get to a physician in time, the damage to
their kidneys could be permanent, and they could end up on
dialysis," cautioned Jain.
The research was released online in advance of publication in
the March print issue of the
Clinical Journal of the American Society of Nephrology.
The U.S. National Institute on Drug Abuse has more about
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.